BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 9399917)

  • 1. PTEN: sometimes taking it off can be better than putting it on.
    Myers MP; Tonks NK
    Am J Hum Genet; 1997 Dec; 61(6):1234-8. PubMed ID: 9399917
    [No Abstract]   [Full Text] [Related]  

  • 2. [Involvement of protein tyrosine phosphatases in cancer development].
    Hinoda Y; Idogawa M; Imai K
    Tanpakushitsu Kakusan Koso; 1998 Jun; 43(8 Suppl):1186-92. PubMed ID: 9655978
    [No Abstract]   [Full Text] [Related]  

  • 3. Identification of a pseudogene that can masquerade as a mutant allele of the PTEN/MMAC1 tumor suppressor gene.
    Whang YE; Wu X; Sawyers CL
    J Natl Cancer Inst; 1998 Jun; 90(11):859-61. PubMed ID: 9625175
    [No Abstract]   [Full Text] [Related]  

  • 4. Inherited mutations in PTEN that are associated with breast cancer, cowden disease, and juvenile polyposis.
    Lynch ED; Ostermeyer EA; Lee MK; Arena JF; Ji H; Dann J; Swisshelm K; Suchard D; MacLeod PM; Kvinnsland S; Gjertsen BT; Heimdal K; Lubs H; Møller P; King MC
    Am J Hum Genet; 1997 Dec; 61(6):1254-60. PubMed ID: 9399897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Germline mutations in PTEN are present in Bannayan-Zonana syndrome.
    Marsh DJ; Dahia PL; Zheng Z; Liaw D; Parsons R; Gorlin RJ; Eng C
    Nat Genet; 1997 Aug; 16(4):333-4. PubMed ID: 9241266
    [No Abstract]   [Full Text] [Related]  

  • 6. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer.
    Li J; Yen C; Liaw D; Podsypanina K; Bose S; Wang SI; Puc J; Miliaresis C; Rodgers L; McCombie R; Bigner SH; Giovanella BC; Ittmann M; Tycko B; Hibshoosh H; Wigler MH; Parsons R
    Science; 1997 Mar; 275(5308):1943-7. PubMed ID: 9072974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disruption of the MMAC1/PTEN gene by deletion or mutation is a frequent event in malignant melanoma.
    Guldberg P; thor Straten P; Birck A; Ahrenkiel V; Kirkin AF; Zeuthen J
    Cancer Res; 1997 Sep; 57(17):3660-3. PubMed ID: 9288767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in primary breast carcinomas.
    Rhei E; Kang L; Bogomolniy F; Federici MG; Borgen PI; Boyd J
    Cancer Res; 1997 Sep; 57(17):3657-9. PubMed ID: 9288766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutation of the PTEN (MMAC1) tumor suppressor gene in a subset of glioblastomas but not in meningiomas with loss of chromosome arm 10q.
    Boström J; Cobbers JM; Wolter M; Tabatabai G; Weber RG; Lichter P; Collins VP; Reifenberger G
    Cancer Res; 1998 Jan; 58(1):29-33. PubMed ID: 9426052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Somatic deletion mapping on chromosome 10 and sequence analysis of PTEN/MMAC1 point to the 10q25-26 region as the primary target in low-grade and high-grade gliomas.
    Maier D; Zhang Z; Taylor E; Hamou MF; Gratzl O; Van Meir EG; Scott RJ; Merlo A
    Oncogene; 1998 Jun; 16(25):3331-5. PubMed ID: 9681833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of PTEN/MMAC1 alterations in uncultured melanomas and melanoma cell lines.
    Tsao H; Zhang X; Benoit E; Haluska FG
    Oncogene; 1998 Jul; 16(26):3397-402. PubMed ID: 9692547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PTEN: life as a tumor suppressor.
    Simpson L; Parsons R
    Exp Cell Res; 2001 Mar; 264(1):29-41. PubMed ID: 11237521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequent PTEN/MMAC mutations in endometrioid but not serous or mucinous epithelial ovarian tumors.
    Obata K; Morland SJ; Watson RH; Hitchcock A; Chenevix-Trench G; Thomas EJ; Campbell IG
    Cancer Res; 1998 May; 58(10):2095-7. PubMed ID: 9605750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PTEN/MMAC1 mutations and EGFR amplification in glioblastomas.
    Liu W; James CD; Frederick L; Alderete BE; Jenkins RB
    Cancer Res; 1997 Dec; 57(23):5254-7. PubMed ID: 9393744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PTEN/MMAC1 mutations in primary glioblastomas and short-term cultures of malignant gliomas.
    Chiariello E; Roz L; Albarosa R; Magnani I; Finocchiaro G
    Oncogene; 1998 Jan; 16(4):541-5. PubMed ID: 9484844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pten signaling in gliomas.
    Knobbe CB; Merlo A; Reifenberger G
    Neuro Oncol; 2002 Jul; 4(3):196-211. PubMed ID: 12084351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Somatic mutations of the PTEN/MMAC1 gene in fifteen Japanese endometrial cancers: evidence for inactivation of both alleles.
    Kurose K; Bando K; Fukino K; Sugisaki Y; Araki T; Emi M
    Jpn J Cancer Res; 1998 Aug; 89(8):842-8. PubMed ID: 9765621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations of the MMAC1/PTEN gene in lymphoid malignancies.
    Grønbaek K; Zeuthen J; Guldberg P; Ralfkiaer E; Hou-Jensen K
    Blood; 1998 Jun; 91(11):4388-90. PubMed ID: 9596690
    [No Abstract]   [Full Text] [Related]  

  • 19. PTEN/MMAC1/TEP1 involvement in primary prostate cancers.
    Pesche S; Latil A; Muzeau F; Cussenot O; Fournier G; Longy M; Eng C; Lidereau R
    Oncogene; 1998 Jun; 16(22):2879-83. PubMed ID: 9671408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers.
    Steck PA; Pershouse MA; Jasser SA; Yung WK; Lin H; Ligon AH; Langford LA; Baumgard ML; Hattier T; Davis T; Frye C; Hu R; Swedlund B; Teng DH; Tavtigian SV
    Nat Genet; 1997 Apr; 15(4):356-62. PubMed ID: 9090379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.